Literature DB >> 8877081

Effects of hypothyroidism on the vulnerability to ventricular fibrillation in dogs: a comparative study with amiodarone.

P Liu1, L Fei, W Wu, J Li, J Wang, X Zhang.   

Abstract

It has been shown that thyroid hormone has a significant effect on the heart and that suppression of thyroid function may contribute to the antiarrhythmic effect of amiodarone. The study was aimed at investigating the effects of hypothyroidism, compared with those of amiodarone, on vulnerability to ventricular fibrillation in dogs. In this study, 25 adult dogs were randomly divided into three groups: a hypothyroid group following total thyroidectomy (n = 9), an amiodarone group (n = 8, 400 mg per day, 4 weeks), and a control group (n = 8). Both amiodarone and control groups were subjected to sham surgery. Five to 8 weeks after surgery, ventricular fibrillation threshold and other electrophysiological parameters were determined. Right ventricular effective refractory period, monophasic action potential duration, and ventricular fibrillation threshold were significantly increased in both the thyroidectomized and amiodarone-treated animals. There was no significant change in monophasic action potential duration dispersion. The incidence of ventricular fibrillation during ischemia and reperfusion was significantly reduced in both treated groups compared with the sham-operated euthyroid controls. These observations suggest that hypothyroidism has a significant antifibrillatory effect in dogs. Homogeneous prolongation of repolarization and refractoriness may contribute to the antifibrillatory action of hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877081     DOI: 10.1007/bf02627962

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  43 in total

1.  Ventricular fibrillation threshold; its physiological and pharmacological importance.

Authors:  E N Moore; J F Spear
Journal:  Arch Intern Med       Date:  1975-03

2.  Beneficial effect of amiodarone on cardiac mortality in patients with asymptomatic complex ventricular arrhythmias after acute myocardial infarction and preserved but not impaired left ventricular function.

Authors:  M Pfisterer; W Kiowski; D Burckhardt; F Follath; F Burkart
Journal:  Am J Cardiol       Date:  1992-06-01       Impact factor: 2.778

3.  Attenuation of class 3 and sinus node effects of amiodarone by experimental hypothyroidism.

Authors:  M Talajic; S Nattel; M Davies; J McCans
Journal:  J Cardiovasc Pharmacol       Date:  1989-03       Impact factor: 3.105

4.  Pharmacokinetics and regional electrophysiological effects of intracoronary amiodarone administration.

Authors:  J N Nanas; J W Mason
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

5.  Effects of chronic administration of amiodarone on kinetics of metabolism of iodothyronines.

Authors:  R Kannan; M Ookhtens; I J Chopra; B N Singh
Journal:  Endocrinology       Date:  1984-11       Impact factor: 4.736

6.  The effect of amiodarone, a new anti-anginal drug, on cardiac muscle.

Authors:  B N Singh; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

7.  [Effects of propafenone, quinidine, and their combination on ventricular fibrillation threshold in dogs].

Authors:  F Lu; X M Zhang; B Y Mei
Journal:  Zhongguo Yao Li Xue Bao       Date:  1992-07

8.  Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.

Authors:  S Melmed; K Nademanee; A W Reed; J A Hendrickson; B N Singh; J M Hershman
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

9.  Post-myocardial infarction mortality in patients with ventricular premature depolarizations. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Pilot Study.

Authors:  J A Cairns; S J Connolly; M Gent; R Roberts
Journal:  Circulation       Date:  1991-08       Impact factor: 29.690

10.  [A case of myxedema heart with serial endomyocardial biopsy].

Authors:  K Fujimoto; M Tagata; M Nagao; Y Suzuki; H Iida; F Kageyama; A Yoshitomi; S Hirose; H Ikegaya; H Okano
Journal:  Kokyu To Junkan       Date:  1992-10
View more
  1 in total

Review 1.  The Role of Thyroid Diseases and their Medications in Cardiovascular Disorders: A Review of the Literature.

Authors:  Negar Omidi; Mohammadrafie Khorgami; Farbod Z Tajrishi; Amirhosein Seyedhoseinpour; Parichehr Pasbakhsh
Journal:  Curr Cardiol Rev       Date:  2020
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.